Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Kneat.com, Inc. (KSI.TO)
Limerick, IE
Kneat.com, Inc. develops and provides specialized software solutions for managing data and documents within highly regulated industries across the United States, Ireland, Canada, and other international markets. Its flagship product, the Kneat Gx platform, is a customizable, ready-to-use application designed to streamline validation lifecycle processes and critical testing procedures specifically for sectors such as biotechnology, pharmaceuticals, and medical device manufacturing. This robust platform supports a wide array of validation activities, including those for processes, computer systems, cleaning, analytical instruments, methods, utilities, facilities, equipment, and cold chains. It also facilitates commissioning, qualification, and electronic logbook management. Beyond its software, Kneat.com offers comprehensive services like user training, system installation, upgrades, ongoing maintenance, consulting, process mapping, and project management. The company's headquarters are located in Limerick, Ireland.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.60% | +9.48% | +18.41% | +23.90% | +25.12% | +3.25% | -22.91% | +86.08% | +70.47% | +681.54% | +681.54% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Healthcare Information Services: +14.2%+29.3% ★ Q1'26: +22.1% (vs Q1'25)
-
EPS growth Medical - Healthcare Information Services: +43.1%+72.3% ★ Q1'26: -287.3% (vs Q1'25)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%+6.2% Q1'26: +41.5% (vs Q1'25)
-
EBIT margin Medical - Healthcare Information Services: +8.8%-13.4% Q1'26: -12.9% (vs Q1'25)
-
ROIC Medical - Healthcare Information Services: +5.2%-16.5% Q1'26: -24.3% (vs Q1'25)
-
Share dilution Medical - Healthcare Information Services: -0.1%+9.7% Q1'26: -2.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×6.32× ★ Q1'26: 4.15× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 4 Rev. Ana. 1 EPS Ana. |
Dec 2028 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.31M
est: 1.32M (-0.7%)
|
3.95M
est: 3.76M (+5.2%)
|
7.42M
est: 6.50M (+14.2%)
|
15.50M
est: 13.68M (+13.3%)
|
23.75M
est: 23.29M (+2.0%)
|
34.22M
est: 33.88M (+1.0%)
|
48.94M
est: 48.99M (-0.1%)
|
63.26M
est: 63.49M (-0.4%)
|
78.27M
76.61M – 79.09M
+23.3% YoY
|
96.63M
92.89M – 98.48M
+23.5% YoY
|
117.32M
114.84M – 118.55M
+21.4% YoY
|
| EBITDA |
-3.06M
est: -211.6K (-1,347.3%)
|
-4.13M
est: -603.7K (-584.8%)
|
-2.30M
est: -1.04M (-120.4%)
|
-5.11M
est: -2.20M (-132.5%)
|
-3.20M
est: -3.74M (+14.5%)
|
-5.37M
est: -5.45M (+1.5%)
|
6.27M
est: 22.11M (-71.7%)
|
5.54M
est: 28.65M (-80.6%)
|
35.32M
34.57M – 35.69M
+23.3% YoY
|
43.61M
41.92M – 44.44M
+23.5% YoY
|
52.95M
51.83M – 53.51M
+21.4% YoY
|
| EBIT |
-4.58M
est: -576.5K (-695.1%)
|
-6.13M
est: -1.65M (-272.5%)
|
-5.50M
est: -2.85M (-93.1%)
|
-9.55M
est: -5.99M (-59.4%)
|
-8.90M
est: -10.20M (+12.7%)
|
-12.98M
est: -14.84M (+12.5%)
|
-3.87M
est: 14.49M (-126.7%)
|
-8.45M
est: 18.77M (-145.0%)
|
23.14M
22.65M – 23.39M
+23.3% YoY
|
28.57M
27.47M – 29.12M
+23.5% YoY
|
34.69M
33.96M – 35.06M
+21.4% YoY
|
| Net Income |
-4.61M
est: -9.09M (+49.3%)
|
-6.33M
est: -8.65M (+26.8%)
|
-5.88M
est: -7.21M (+18.4%)
|
-9.86M
est: -12.12M (+18.6%)
|
-9.15M
est: -12.64M (+27.6%)
|
-14.12M
est: -16.07M (+12.2%)
|
-7.73M
est: -8.87M (+12.8%)
|
-2.35M
est: -1.21M (-93.8%)
|
-8.54M
-8.66M – -8.31M
-604.9% YoY
|
2.28M
2.22M – 2.31M
+126.7% YoY
|
7.59M
7.38M – 7.70M
+233.3% YoY
|
| SGA |
2.94M
est: 718.3K (+309.8%)
|
3.39M
est: 2.05M (+65.3%)
|
4.13M
est: 3.55M (+16.4%)
|
7.35M
est: 7.47M (-1.6%)
|
13.44M
est: 12.71M (+5.7%)
|
20.98M
est: 18.50M (+13.4%)
|
25.44M
est: 26.60M (-4.4%)
|
34.31M
est: 34.47M (-0.5%)
|
42.50M
41.60M – 42.94M
+23.3% YoY
|
52.47M
50.44M – 53.47M
+23.5% YoY
|
63.70M
62.35M – 64.37M
+21.4% YoY
|
| EPS |
-0.09
est: -0.11 (+11.4%)
|
-0.11
est: -0.10 (-10.0%)
|
-0.09
est: -0.08 (-7.2%)
|
-0.13
est: -0.14 (+7.1%)
|
-0.12
est: -0.15 (+17.8%)
|
-0.18
est: -0.19 (+3.1%)
|
-0.09
est: -0.09 (+4.4%)
|
-0.02
est: -0.01 (-93.5%)
|
-0.09
-0.09 – -0.09
-604.9% YoY
|
0.02
0.02 – 0.02
+126.7% YoY
|
0.08
0.08 – 0.08
+233.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares S&P/TSX SmallCap Index ETF XCS.TO | 0.16% | 273.4K | 0.60% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jacob Hahn Michelsen | Senior Vice President of Sales & Marketing | 575.9K | male |
| Edmund Ryan | Co-Founder, Chief Executive Officer, President & Executive Director | 473.8K | male |
| Kevin Fitzgerald | Co-founder & Chief Innovation Officer | 343.3K | male |
| Keith Holmes | Chief Technology Officer | 334.9K | male |
| Brian Ahearne | Co-Founder, Director of Information Security & IT Operations and Company Secretary | 327.7K | male |
| Dave O'Reilly | Chief Financial Officer | 286.6K | male |
| Fiona McCarthy | Chief People & Culture Officer | — | female |
| Donal O'Sullivan | Chief Product Officer | — | male |
| Katie Keita | IR Lead | — | female |
| Colum McNamara | Senior Vice President of Global Operations | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for KSI.TO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
